平安中证医疗创新ETF(516820)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/12/31 |
3,863,420,000 |
4,953,420,000 |
2,586,000,000 |
1,496,000,000 |
1,090,000,000 |
28.21% |
2024/9/30 |
3,777,420,000 |
3,863,420,000 |
1,384,000,000 |
1,298,000,000 |
86,000,000 |
2.28% |
2024/6/30 |
2,990,420,000 |
3,777,420,000 |
1,797,000,000 |
1,010,000,000 |
787,000,000 |
26.32% |
2024/6/30 |
3,205,420,000 |
3,777,420,000 |
949,000,000 |
377,000,000 |
572,000,000 |
17.84% |
2024/3/31 |
2,990,420,000 |
3,205,420,000 |
848,000,000 |
633,000,000 |
215,000,000 |
7.19% |
2023/12/31 |
1,575,420,000 |
2,990,420,000 |
4,012,000,000 |
2,597,000,000 |
1,415,000,000 |
89.82% |
2023/12/31 |
3,185,420,000 |
2,990,420,000 |
540,000,000 |
735,000,000 |
-195,000,000 |
-6.12% |
2023/9/30 |
2,920,420,000 |
3,185,420,000 |
1,459,000,000 |
1,194,000,000 |
265,000,000 |
9.07% |
2023/6/30 |
1,575,420,000 |
2,920,420,000 |
2,013,000,000 |
668,000,000 |
1,345,000,000 |
85.37% |
2023/6/30 |
1,846,420,000 |
2,920,420,000 |
1,341,000,000 |
267,000,000 |
1,074,000,000 |
58.17% |
2023/3/31 |
1,575,420,000 |
1,846,420,000 |
672,000,000 |
401,000,000 |
271,000,000 |
17.2% |
2022/12/31 |
1,238,420,000 |
1,575,420,000 |
1,317,000,000 |
980,000,000 |
337,000,000 |
27.21% |
2022/12/31 |
1,669,420,000 |
1,575,420,000 |
249,000,000 |
343,000,000 |
-94,000,000 |
-5.63% |
2022/9/30 |
1,277,420,000 |
1,669,420,000 |
565,000,000 |
173,000,000 |
392,000,000 |
30.69% |
2022/6/30 |
1,238,420,000 |
1,277,420,000 |
503,000,000 |
464,000,000 |
39,000,000 |
3.15% |
2022/6/30 |
1,300,420,000 |
1,277,420,000 |
165,000,000 |
188,000,000 |
-23,000,000 |
-1.77% |
2022/3/31 |
1,238,420,000 |
1,300,420,000 |
338,000,000 |
276,000,000 |
62,000,000 |
5.01% |
2021/12/31 |
1,134,420,000 |
1,238,420,000 |
871,000,000 |
767,000,000 |
104,000,000 |
9.17% |
2021/12/31 |
1,070,420,000 |
1,238,420,000 |
348,000,000 |
180,000,000 |
168,000,000 |
15.69% |
2021/9/30 |
1,134,420,000 |
1,070,420,000 |
523,000,000 |
587,000,000 |
-64,000,000 |
-5.64% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。